Comparison of ACT Between Hemochron Jr and ACT Plus
Comparison of Activated Coagulation Time Between Hemochron Jr and ACT Plus During Cardiac Surgery for Patient Using Acute Normovolemic Hemodilution
1 other identifier
interventional
26
1 country
1
Brief Summary
This study aimed to compare 2 activated clotting time analysers (Hemochron Jr vs. ACT Plus).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2012
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2014
CompletedFirst Submitted
Initial submission to the registry
June 25, 2015
CompletedFirst Posted
Study publicly available on registry
June 29, 2015
CompletedJune 29, 2015
December 1, 2012
1 year
June 25, 2015
June 26, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Comparison of activated coagulation time between Hemochron Jr and ACT Plus
During cardiac surgeris (within 8 hours)
Study Arms (1)
Patient
EXPERIMENTALPatients were checked activated coagulation time by both Hemochron Jr and ACT Plus during cardiac surgery with heparin administration.
Interventions
Eligibility Criteria
You may qualify if:
- Patients who underwent cardiac surgery with heparin administration.
You may not qualify if:
- Preoperative hemoglobin under 11g/dL
- Weight under 40kg
- Preoperative coagulopathy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hallym University Sacred Heart Hospital
Anyang-si, Gyeonggi-do, KS009, South Korea
Related Publications (4)
Svenmarker S, Appelblad M, Jansson E, Haggmark S. Measurement of the activated clotting time during cardiopulmonary bypass: differences between Hemotec ACT and Hemochron Jr apparatus. Perfusion. 2004;19(5):289-94. doi: 10.1191/0267659104pf755oa.
PMID: 15506033BACKGROUNDChia S, Van Cott EM, Raffel OC, Jang IK. Comparison of activated clotting times obtained using Hemochron and Medtronic analysers in patients receiving anti-thrombin therapy during cardiac catheterisation. Thromb Haemost. 2009 Mar;101(3):535-40.
PMID: 19277416BACKGROUNDBosch YP, Weerwind PW, Nelemans PJ, Maessen JG, Mochtar B. An evaluation of factors affecting activated coagulation time. J Cardiothorac Vasc Anesth. 2012 Aug;26(4):563-8. doi: 10.1053/j.jvca.2012.03.011. Epub 2012 Apr 24.
PMID: 22534410BACKGROUNDDalbert S, Ganter MT, Furrer L, Klaghofer R, Zollinger A, Hofer CK. Effects of heparin, haemodilution and aprotinin on kaolin-based activated clotting time: in vitro comparison of two different point of care devices. Acta Anaesthesiol Scand. 2006 Apr;50(4):461-8. doi: 10.1111/j.1399-6576.2006.00990.x.
PMID: 16548858BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Soo Kyung Lee, MD
Hallym University Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 25, 2015
First Posted
June 29, 2015
Study Start
December 1, 2012
Primary Completion
December 1, 2013
Study Completion
January 1, 2014
Last Updated
June 29, 2015
Record last verified: 2012-12